1. Extensive Use of Interventional Therapies Improves Survival in Unresectable or Recurrent Intrahepatic Cholangiocarcinoma
   Ricarda Seidensticker et al, 2016, Gastroenterology Research and Practice CrossRef
2. Tumor infiltrating lymphocytes in gastrointestinal tumors: Controversies and future clinical implications
   Cinzia Solinas et al, 2017, Critical Reviews in Oncology/Hematology CrossRef
3. The role of minimally invasive surgery in the treatment of cholangiocarcinoma
   G.B. Levi Sandri et al, 2017, European Journal of Surgical Oncology (EJSO) CrossRef
4. Liver resection for intrahepatic cholangiocarcinoma in AJCC-stage IV: An evaluation of the survival benefit and prognostic accuracy of current AJCC staging system on N and M classification
   Lei Yuan et al, 2016 CrossRef
5. miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma.
   Jisce R Puik et al, 2017, Pharmacogenomics CrossRef
6. Neutrophil-to-lymphocyte ratio predicts prognosis after neoadjuvant chemotherapy and resection of intrahepatic cholangiocarcinoma
   Kiyohiko Omichi et al, 2017, Surgery CrossRef
7. Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent
   X.-F. Zhang et al, 2017, Br J Surg CrossRef
8. Osthole induces apoptosis and suppresses proliferation via the PI3K/Akt pathway in intrahepatic cholangiocarcinoma
   Xingyang Zhu et al, 2017 CrossRef
9. Overexpression of the X-linked ribosomal protein S4 predicts poor prognosis in patients with intrahepatic cholangiocarcinoma
   Jie Kuang et al, 2017 CrossRef
10. null
    Thomas Aloia et al, 2017 CrossRef
11. Visceral infiltration of intrahepatic cholangiocarcinoma is most prognostic after curative resection - Retrospective cohort study of 102 consecutive liver resections from a single center
    Fabian Bartsch et al, 2018, International Journal of Surgery CrossRef
12. Thermal ablation of intrahepatic cholangiocarcinoma: Safety, efficacy, and factors affecting local tumor progression
    Edwin A. Takahashi et al, 2018, Abdom Radiol CrossRef
13. Photodynamic Therapy in Patients with Advanced Hilar Cholangiocarcinoma: Percutaneous Cholangioscopic Versus Peroral Transpapillary Approach
    Tae Yoon Lee et al, 2016, Photomedicine and Laser Surgery CrossRef
14. null
    Marco Massani et al, 2018 CrossRef
15. Endoscopic mucosal resection for intraductal growing-type intrahepatic cholangiocarcinoma under direct peroral cholangioscopy
    Jang Han Jung et al, 2018, Digestive Endoscopy CrossRef
16. Adjuvant chemotherapy improves oncological outcomes of resectable intrahepatic cholangiocarcinoma
    Ka Wing Ma et al, 2019, Medicine CrossRef
17. Yttrium-90 Radioembolization Is Cost Effective in Intrahepatic Cholangiocarcinoma: A SEER Medicare Population Study
    Anish Ghodadra et al, 2019, Journal of Vascular and Interventional Radiology CrossRef
18. Trends in the Incidence, Treatment and Outcomes of Patients with Intrahepatic Cholangiocarcinoma in the USA: Facility Type is Associated with Margin Status, Use of Lymphadenectomy and Overall Survival
    Lu Wu et al, 2019, World J Surg CrossRef
19. Role of Lymph Node Dissection in Small (≤ 3 cm) Intrahepatic Cholangiocarcinoma
    Andrea Ruzzenente et al, 2019, J Gastrointest Surg CrossRef
20. Imaging bile duct tumors: staging
    Juan-Ramón Ayuso et al, 2013, Abdom Imaging CrossRef
21. Identification of prognostic factors and the impact of palliative resection on survival of patients with stage IV hepatolithiasis-associated intrahepatic cholangiocarcinoma
    Guo-wei Zhang et al, 2014, J. Surg. Oncol. CrossRef
22. Survival Outcomes and Prognostic Factors of Surgical Therapy for All Potentially Resectable Intrahepatic Cholangiocarcinoma: a Large Single-Center Cohort Study
    Xianwu Luo et al, 2014, J Gastrointest Surg CrossRef
23. Science to Practice: Can We Turn the Undesired Heating Effects of MR Imaging into Effective Cancer Therapies?
    S. Nahum Goldberg, 2014, Radiology CrossRef
24. Intrahepatic Cholangiocarcinoma
    Kimberly M. Brown et al, 2014, Surgical Oncology Clinics of North America CrossRef
25. Temporal trends in liver-directed therapy of patients with intrahepatic cholangiocarcinoma in the United States: A population-based analysis
    Neda Amini et al, 2014, J. Surg. Oncol. CrossRef
26. Identification of Risk and Prognostic Factors for Patients with Clonorchiasis-Associated Intrahepatic Cholangiocarcinoma
    Guo-Wei Zhang et al, 2014, Ann Surg Oncol CrossRef
27. ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma
    Daniel S. Strand et al, 2014, Gastrointestinal Endoscopy CrossRef
28. Efficacy of Hepatic Arterial Infusion Chemotherapy Using 5-Fluorouracil and Systemic Pegylated Interferon α-2b for Advanced Intrahepatic Cholangiocarcinoma
    Kazuhiro Kasai et al, 2014, Ann Surg Oncol CrossRef
29. The Expression of S100A4 Protein in Human Intrahepatic Cholangiocarcinoma: Clinicopathologic Significance and Prognostic Value
    Xiangguo Tian et al, 2015, Pathol. Oncol. Res. CrossRef
30. Stereotactic body radiotherapy for liver tumors
    Florian Sterzing et al, 2014, Strahlenther Onkol CrossRef
31. Prognostic Risk Factors Associated with Recurrence and Metastasis After Radical Resection in Patients with Hepatolithiasis Complicated by Intrahepatic Cholangiocarcinoma
    Yufei Zhu et al, 2015, Cell Biochem Biophys CrossRef
32. Intrahepatic cholangiocarcinomas mimicking other lesions
    Sharon Z. Adam et al, 2015, Abdom Imaging CrossRef
33. Inoperable Biliary Tract and Primary Liver Tumors
    Sophia K. McKinley et al, 2019, Surgical Oncology Clinics of North America CrossRef
34. Suivi après radiothérapie stéréotaxique des tumeurs hépatiques : revue de la littérature et recommandations
    G. Janoray et al, 2015, Cancer/Radiothérapie CrossRef
35. Multimodality treatment of intrahepatic cholangiocarcinoma: A review
    Kerri A. Simo et al, 2016, J. Surg. Oncol.  CrossRef
36. Preoperative Ultrasound Radiomics Signatures for Noninvasive Evaluation of Biological Characteristics of Intrahepatic Cholangiocarcinoma
    Yu-ting Peng et al, 2019, Academic Radiology CrossRef
37. Diagnostic value of microRNAs as biomarkers for cholangiocarcinoma
    Zhenzhen Liang et al, 2016, Digestive and Liver Disease CrossRef
38. Stereotactic body radiotherapy for primary hepatic malignancies – Report of a phase I/II institutional study
    Ashley A. Weiner et al, 2016, Radiotherapy and Oncology CrossRef
39. null
    Alireza Rezaee et al, 2018 CrossRef
40. Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma
    Torsten Voigtländer et al, 2020, J Biomed Sci CrossRef
41. Endogenous CXCL9 affects prognosis by regulating tumor‐infiltrating natural killer cells in intrahepatic cholangiocarcinoma
    Yasunari Fukuda et al, 2020, Cancer Sci CrossRef
42. Prognostic impact of hepatitis B or C on intrahepatic cholangiocarcinoma
    Jung Woong Seo et al, 2020, Korean J Intern Med CrossRef
43. Prognostic factors predicting survival rate over 10 years of patients with intrahepatic cholangiocarcinoma after hepatic resection
    Chung Hyeun Ma et al, 2020, Ann Surg Treat Res CrossRef
44. Relevance of suspicious lymph nodes in preoperative imaging for resectability, recurrence and survival of intrahepatic cholangiocarcinoma
    Fabian Bartsch et al, 2020, BMC Surg CrossRef
45. Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma
    Guohe Lin et al, 2016, Oncotarget CrossRef
46. Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experience
    Giovanni Brandi et al, 2020, International Journal of Hyperthermia CrossRef
47. MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN
    Li-Juan Wang et al, 2015, Oncotarget CrossRef
48. Intrahepatic cholangiocarcinoma: pathogenesis, current staging, and radiological findings
    Mohammed Saleh et al, 2020, Abdom Radiol CrossRef
49. Factors affecting the response to Y-90 microsphere therapy in the cholangiocarcinoma patients
    Mehmet Bozkurt et al, 2020, Radiol med CrossRef
50. Chromomycin A3 suppresses cholangiocarcinoma growth by induction of S phase cell cycle arrest and suppression of Sp1‑related anti‑apoptotic proteins
    Paksiree Saranaruk et al, 2020, Int J Mol Med CrossRef
51. Downregulation of ABCA1 and ABCG1 transporters by simvastatin in cholangiocarcinoma cells
    Pattaya Seeree et al, 2019, Oncol Lett CrossRef
52. Bioprinting of patient-derived in vitro intrahepatic cholangiocarcinoma tumor model: establishment, evaluation and anti-cancer drug testing
    Shuangshuang Mao et al, 2020, Biofabrication CrossRef
53. Spectrum of Cholangiocarcinoma with Special Emphasis on Treatment Modalities and Outcome at a Rural Tertiary Care Centre
    Dwaipayan Samaddar et al, 2020, jemds CrossRef
54. Intrahepatic cholangiocarcinoma: Introducing the preoperative prediction score based on preoperative imaging
    Fabian Bartsch et al, 2020, Hepatobiliary & Pancreatic Diseases International CrossRef
55. Radiofrequency Ablation vs. Surgical Resection for Small Early-Stage Primary Intrahepatic Cholangiocarcinoma
    Xin Xiang et al, 2020, Front. Oncol. CrossRef
56. Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression.
    Alphonse E Sirica et al, 2021, Adv Cancer Res CrossRef
57. The Evolving Role of Radiation Therapy in the Treatment of Biliary Tract Cancer
    Eleni Gkika et al, 2020, Front. Oncol. CrossRef
58. Repeated resection for recurrent intrahepatic cholangiocarcinoma: A retrospective German multicentre study
    Fabian Bartsch et al, 2021, Liver Int CrossRef
59. Place de la radiothérapie des cholangiocarcinomes intra- et extrahépatiques
    J. Moreau et al, 2021, Cancer/Radiothérapie CrossRef
60. Clinically significant genomic alterations in the Chinese and Western patients with intrahepatic cholangiocarcinoma
    Shifeng Xu et al, 2021, BMC Cancer CrossRef
61. null
    Feng Shen et al, 2021 CrossRef
62. null
    Russell C. Kirks et al, 2021 CrossRef
63. Influence of Lymphangio (L), Vascular (V), and Perineural (Pn) Invasion on Recurrence and Survival of Resected Intrahepatic Cholangiocarcinoma
    Fabian Bartsch et al, 2021, JCM CrossRef
64. Volumetric CT Texture Analysis of Intrahepatic Mass-Forming Cholangiocarcinoma for the Prediction of Postoperative Outcomes: Fully Automatic Tumor Segmentation Versus Semi-Automatic Segmentation
    Sungeun Park et al, 2021, Korean J Radiol CrossRef
65. The preoperative prognostic value of the radiomics nomogram based on CT combined with machine learning in patients with intrahepatic cholangiocarcinoma
    Youyin Tang et al, 2021, World J Surg Onc CrossRef
66. Liver Resection for Intrahepatic Cholangiocarcinoma—Single-Center Experience with 286 Patients Undergoing Surgical Exploration over a Thirteen Year Period
    Hauke Lang et al, 2021, JCM CrossRef
67. Geographic Disparities in Referral Rates and Oncologic Outcomes of Intrahepatic Cholangiocarcinoma: A Population-Based Study
    Thomas L. Sutton et al, 2021, Ann Surg Oncol CrossRef
68. Individualised dosimetry and safety of SIRT for intrahepatic cholangiocarcinoma
    Kathy P. Willowson et al, 2021, EJNMMI Phys CrossRef
69. Challenges and Opportunities for Treating Intrahepatic Cholangiocarcinoma
    Nikolaos Serifis et al, 2021, HMER CrossRef
70. Surgical management of intrahepatic cholangiocarcinoma.
    D Brock Hewitt et al, 2022, Expert Rev Anticancer Ther CrossRef
71. Selection criteria for minimally invasive resection of intrahepatic cholangiocarcinoma—a word of caution: a propensity score matched analysis using the national cancer database
    Omid Salehi et al, 2021, Surg Endosc CrossRef
72. Endobiliary Ablation Improves Survival in Patients with Unresectable Perihilar Cholangiocarcinoma Compared to Stenting Alone
    Ross C.D. Buerlein et al, 2022, Techniques and Innovations in Gastrointestinal Endoscopy CrossRef
73. Comparing Survival Outcomes of Patients With LI‐RADS‐M Hepatocellular Carcinomas and Intrahepatic Cholangiocarcinomas
    Andrea S. Kierans et al, 2022, Magnetic Resonance Imaging CrossRef
74. Statins associate with lower risk of biliary tract cancers: A systematic review and meta‐analysis
    Ka Shing Cheung et al, 2022, Cancer Medicine CrossRef
75. Is There Any Evidence for a Role of Local Treatment in Cholangiocarcinoma?
    Arndt Vogel et al, 2014, Visc Med CrossRef
76. Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians
    Dimitrios Moris et al, 2022, CA A Cancer J Clinicians CrossRef
77. Surgical Aspects of Intrahepatic Cholangiocarcinoma
    Amram Kupietzky et al, 2022, Cancers CrossRef
78. Predictive factors of microvascular invasion in patients with intrahepatic mass-forming cholangiocarcinoma based on magnetic resonance images
    Shuang Chen et al, 2023, Abdom Radiol CrossRef
79. Socioeconomic and Survival Analysis of Radioembolization in Patients with Intrahepatic Cholangiocarcinoma: A Propensity Score–Adjusted Study
    Xiao Wu et al, 2023, Journal of Vascular and Interventional Radiology CrossRef
80. Role of sex in liver tumor occurrence and clinical outcomes: a comprehensive review
    Pierluigi Toniutto et al, 2023 CrossRef
81. Development and validation of a machine learning-based early prediction model for massive intraoperative bleeding in patients with primary hepatic malignancies
    Jin Li et al, 2024, World J Gastrointest Oncol CrossRef
82. Contemporary Trends and Outcomes after Liver Transplantation and Resection for Intrahepatic Cholangiocarcinoma
    Thomas Clark Howell et al, 2024, Journal of Gastrointestinal Surgery CrossRef